MENU
+Compare
SCNI
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$2.28
Change
-$0.19 (-7.69%)
Capitalization
2.28M

SCNI Scinai Immunotherapeutics Ltd. Forecast, Technical & Fundamental Analysis

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai’s drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies... Show more

SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SCNI with price predictions
Jun 27, 2025

SCNI in downward trend: price dove below 50-day moving average on June 06, 2025

SCNI moved below its 50-day moving average on June 06, 2025 date and that indicates a change from an upward trend to a downward trend. In of 50 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SCNI as a result. In of 110 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for SCNI crossed bearishly below the 50-day moving average on June 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCNI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SCNI broke above its upper Bollinger Band on June 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 82 cases where SCNI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SCNI just turned positive on June 25, 2025. Looking at past instances where SCNI's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 49 cases where SCNI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.524) is normal, around the industry mean (16.366). P/E Ratio (1.188) is within average values for comparable stocks, (58.189). SCNI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (2.794) is also within normal values, averaging (252.247).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SCNI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCNI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SCNI is expected to report earnings to fall 3,548.28% to -10 cents per share on May 02

Scinai Immunotherapeutics Ltd. SCNI Stock Earnings Reports
Q4'22
Est.
$-0.10
Q3'22
Beat
by $0.10
Q2'22
Est.
$-0.01
Q1'22
Est.
$0.00
The last earnings report on November 30 showed earnings per share of 0 cents, beating the estimate of -10 cents. With 45.32K shares outstanding, the current market capitalization sits at 2.28M.
A.I. Advisor
published General Information

General Information

a manufacturer of the innovative flu vaccine

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
33
Web
https://www.biondvax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
U24.320.92
+3.93%
Unity Software
SHYF12.640.01
+0.08%
Shyft Group (The)
VECO20.52-0.70
-3.30%
Veeco Instruments
GAIA4.50-0.37
-7.60%
Gaia
ENTO0.38-0.06
-12.87%
Entero Therapeutics Inc.

SCNI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with WINT. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-7.69%
WINT - SCNI
89%
Closely correlated
+21.49%
NBY - SCNI
88%
Closely correlated
+0.97%
NCNA - SCNI
88%
Closely correlated
N/A
SNPX - SCNI
88%
Closely correlated
+23.37%
RNAC - SCNI
86%
Closely correlated
-6.81%
More

Groups containing SCNI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-7.69%
SCNI
(19 stocks)
10%
Poorly correlated
+0.46%